Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests a possible link between mast cells and scarring alopecia, recommending more research for potential treatments.

Low vitamin D levels are linked to hair loss, and vitamin D might help treat it.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

Some vitamin D analogs can thicken skin and reduce pore size like a common acne treatment, with one analog also affecting skin growth factors.

Topical calcitriol-analogs can reduce hair loss caused by chemotherapy.

Adding a specific gene to skin cells can help treat skin disorders like psoriasis.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Vitamin D made by the skin plays a role in immune defense and skin health, and more research is needed to understand its full effects.

The vitamin D receptor helps maintain hair and bone health even without binding vitamin D.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

Vitamin D and its receptor regulate skin functions like cell growth, immunity, hair cycle, and tumor prevention.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

Low vitamin D levels might indicate more severe hair loss in alopecia areata patients.

Vitamin D receptor helps control hair growth and could be used to treat certain skin tumors.

Skin symptoms can indicate endocrine disorders and have various treatments.

Modulating Cytochrome P450 activity could help develop new skin disease treatments.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

The document gives treatment advice for various skin conditions, like using metronidazole for perioral dermatitis and minoxidil for hair loss.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Calcipotriene ointment improved a child's skin condition known as En coup de sabre.

Scalp psoriasis can cause different types of hair loss, with some patients developing permanent hair loss, and treatment may be stopped due to skin reactions.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

The document concludes that different types of hair loss have specific treatments, and early diagnosis is crucial for preventing permanent hair loss.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.